SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
Por:
Martin-Richard, M, Beveridge, RD, Arrazubi, V, Alsina, M, Guzman, MG, Custodio, AB, Gomez, C, Munoz, FL, Pazo, R, Rivera, F
Publicada:
1 dic 2016
Resumen:
Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization and underlying factors which are the principal cause of the recent incidence changes observed in west countries. Staging techniques and treatment options which combine surgery, chemotherapy and radiotherapy, reflected the high complexity of the EC management. An undeniably multidisciplinary approach is, therefore, required. In this guide, we review the status of current diagnosis and treatment, define evidence and propose recommendations.
Filiaciones:
Martin-Richard, M:
Hosp Santa Creu & Sant Pau, Serv Oncol Med, Dept Med Oncol, St Antoni Maria Claret 167, Barcelona 08025, Spain
Beveridge, RD:
Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain
Arrazubi, V:
Hosp Basurto, Dept Med Oncol, Bilbao, Spain
Alsina, M:
Hosp Valle De Hebron, Dept Med Oncol, Barcelona, Spain
Guzman, MG:
Hosp Duran & Reynals ICO, Dept Med Oncol, Lhospitalet De Llobregat, Spain
Custodio, AB:
Hosp Univ La Paz, Madrid, Spain
Gomez, C:
Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
Munoz, FL:
Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
Pazo, R:
Hosp Univ Miguel Servet, Dept Med Oncol, Zaragoza, Spain
Rivera, F:
Hosp Univ Marques Valdecilla, Dept Med Oncol, Santander, Spain
Hybrid Gold, Green Published
|